Table 1.
Degree of Stunting at Follow-up, No. (%)a | |||||
---|---|---|---|---|---|
Degree of Stunting at Enrollment by Age Group | Total | None | Mild | Moderate | Severe |
Age 0–11 mo | |||||
Total | 3408 | 1414 (41.5) | 1093 (32.1) | 616 (18.1) | 285 (8.3) |
None | 1727 (50.7) | 1302 (75.4) | 391 (22.6) | 32 (1.9) | 2 (0.1) |
Mild | 1049 (30.8) | 104 (9.9) | 640 (61.0) | 291 (27.7) | 14 (1.3) |
Moderate | 435 (12.7) | 8 (1.8) | 57 (13.1) | 257 (59.1) | 113 (26.0) |
Severe | 197 (5.8) | 0 | 5 (2.5) | 36 (18.3) | 156 (79.2) |
Age 12–23 mo | |||||
Total | 2741 | 838 (30.6) | 951 (34.7) | 591 (21.6) | 361 (13.2) |
None | 998 (36.4) | 774 (77.6) | 222 (22.2) | 2 (0.2) | 0 |
Mild | 911 (33.2) | 63 (6.9) | 654 (71.8) | 191 (21.0) | 3 (0.3) |
Moderate | 556 (20.3) | 1 (0.2) | 74 (13.3) | 374 (67.3) | 107 (19.2) |
Severe | 276 (10.1) | 0 | 1 (0.4) | 24 (8.7) | 251 (90.9) |
Age 24–59 mo | |||||
Total | 1928 | 582 (30.2) | 647 (33.6) | 457 (23.7) | 242 (12.6) |
None | 612 (31.7) | 528 (86.3) | 84 (13.7) | 0 | 0 |
Mild | 642 (33.3) | 54 (8.4) | 509 (79.3) | 79 (12.3) | 0 |
Moderate | 462 (24.0) | 0 | 54 (11.7) | 358 (77.5) | 50 (10.8) |
Severe | 212 (11.0) | 0 | 0 | 20 (9.4) | 192 (90.6) |
aFollow-up visits were approximately 60 days after enrollment (range, 49–91 days). Stunting was significantly more severe at follow-up in all 3 age groups (P < .001; Wilcoxon signed-rank test). The degree of stunting was defined according to height-for-age z scores (HAZ), No stunting defined as HAZ ≥ −1, with mild stunting defined as HAZ between <−1 and >/+−2, moderate stunting as HAZ between <−2 and ≥−3, and severe stunting as HAZ below <−3.